Influenza A Virus, H3N2 Subtype

• 

  Subject Areas on Research

  • A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection. 
  • A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. 
  • A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. 
  • A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged. 
  • An individualized predictor of health and disease using paired reference and target samples. 
  • Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection. 
  • Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. 
  • Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification. 
  • Detection of viruses via statistical gene expression analysis. 
  • Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. 
  • Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge. 
  • Differential pulmonary transcriptomic profiles in murine lungs infected with low and highly virulent influenza H3N2 viruses reveal dysregulation of TREM1 signaling, cytokines, and chemokines. 
  • Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction. 
  • H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. 
  • High Risk of Influenza Virus Infection Among Swine Workers: Examining a Dynamic Cohort in China. 
  • Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. 
  • Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. 
  • Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope. 
  • Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? 
  • Iridoids and sesquiterpenoids from Valeriana jatamansi and their anti-influenza virus activities. 
  • Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections. 
  • Nasopharyngeal Protein Biomarkers of Acute Respiratory Virus Infection. 
  • Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection. 
  • Pattern recognition molecule mindin promotes intranasal clearance of influenza viruses. 
  • Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013. 
  • Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. 
  • Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents. 
  • Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. 
  • The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. 
  • The impact of host immune status on the within-host and population dynamics of antigenic immune escape. 
  • Unsupervised Bayesian linear unmixing of gene expression microarrays. 
• 

  Keywords of People

  • McClain, Micah Thomas, Associate Professor of Medicine, Medicine, Infectious Diseases